BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6458672)

  • 21. [Laboratory and clinical studies of T-1982 (cefbuperazone) in pediatrics].
    Sekiguchi T; Ichioka T; Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1983 Apr; 36(4):869-76. PubMed ID: 6348341
    [No Abstract]   [Full Text] [Related]  

  • 22. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
    Kaplan SL; Mason EO; Kvernland SJ; Loiselle EM; Feigin RD
    Pediatrics; 1983 Feb; 71(2):187-91. PubMed ID: 6218472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
    Kaplan SL; Mason EO; Garcia H; Kvernland SJ; Loiselle EM; Anderson DC; Mintz AA; Feigin RD
    J Pediatr; 1981 Jan; 98(1):152-7. PubMed ID: 6450278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of moxalactam for bacterial meningitis.
    Kaplan SL; Mason EO; Feigin RD
    J Pediatr; 1982 May; 100(5):843. PubMed ID: 6461736
    [No Abstract]   [Full Text] [Related]  

  • 26. Moxalactam.
    Lancet; 1981 Jul; 2(8236):23-4. PubMed ID: 6113400
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Barriere SL; Wilson CB; Pons VG
    Neurosurgery; 1982 Jun; 10(6 Pt 1):762-5. PubMed ID: 6213879
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 30. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxalactam in the treatment of pediatric infections.
    Yogev R; Schreiber M; Gardner S; Shulman ST
    Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH; Schaad UB
    Rev Infect Dis; 1982; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract]   [Full Text] [Related]  

  • 33. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
    Simard P; Bergeron MG
    J Antimicrob Chemother; 1982 Nov; 10(5):397-402. PubMed ID: 6294044
    [No Abstract]   [Full Text] [Related]  

  • 34. Moxalactam for the treatment of bacterial meningitis in children.
    Freedman JM; Hoffman SH; Scheld WM; Lynch MA; da Silva HR; Rocha H; Sande MA
    J Infect Dis; 1983 Nov; 148(5):886-91. PubMed ID: 6415181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
    Fisher JF; Carter MJ; Parsons J; Rissing JP
    Antimicrob Agents Chemother; 1981 Feb; 19(2):218-21. PubMed ID: 6214985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxalactam therapy of Haemophilus influenzae type b meningitis in children.
    Chartrand SA; Marks MI; Scribner RK; Johnston JT; Frederick DF
    J Pediatr; 1984 Mar; 104(3):454-9. PubMed ID: 6608581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moxalactam therapy for bacterial pneumonia.
    Perlino CA
    Rev Infect Dis; 1982; 4 Suppl():S617-22. PubMed ID: 6218574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial meningitis: is there a "best" antimicrobial therapy?
    Eichenwald HF
    Eur J Pediatr; 1987 May; 146(3):216-20. PubMed ID: 3297707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.